Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

135
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
135
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

708
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
708
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

588
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
588
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

1.2K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.2K
Asymmetric Lipid Bilayer01:35

Asymmetric Lipid Bilayer

7.2K
Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...
7.2K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

519
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
519

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Measurement of low-density lipoprotein cholesterol and other circulating lipids in Brazil: a systematic literature review.

Clinica chimica acta; international journal of clinical chemistry·2026
Same author

High-Density Lipoprotein-Specific Phospholipid Efflux (HDL-SPE) Assay in Mice.

Molecular nutrition & food research·2026
Same author

In Reply to Inter-Instrument Imprecision Complements Bias in Evaluating LDL-C Method Performance.

Clinical chemistry·2026
Same author

Corrigendum to "Identification of a novel apoB variant in a family exhibiting hypocholesterolemia: Mechanistic insights" [J Clin Lipidol (2026) S1933-2874(26)00045-0, ahead of print].

Journal of clinical lipidology·2026
Same author

Permanent Lipid Lowering with CRISPR-Based Interventions: Redefining Laboratory Medicine in the Era of Gene Editing.

Clinical chemistry·2026
Same author

Evaluation of Analytical Performance Specifications for Clinical Laboratory Tests Based on Test Misclassification.

The journal of applied laboratory medicine·2026
Same journal

Neuromyelitis optica spectrum disorder: a 5-year experience in a tertiary hospital in Northern Vietnam.

Multiple sclerosis and related disorders·2026
Same journal

Cell-type-specific Mendelian randomization analysis of brain single-nucleus eQTLs and neuromyelitis optica spectrum disorder risk.

Multiple sclerosis and related disorders·2026
Same journal

Detection of Aquaporin-4 antibody in cerebrospinal fluid in neuromyelitis optica spectrum disorder.

Multiple sclerosis and related disorders·2026
Same journal

Adjunctive gypenosides for acute optic neuritis: A prematurely terminated randomized, double-blind, placebo-controlled pilot trial in a cohort with frequent AQP4-IgG positivity.

Multiple sclerosis and related disorders·2026
Same journal

Genetic and molecular architecture of multiple sclerosis in gulf cooperation council populations: A scoping review and regional precision-neurology perspective.

Multiple sclerosis and related disorders·2026
Same journal

Rising burden and future projections of multiple sclerosis in East Asia: Findings from the global burden of disease study 2021.

Multiple sclerosis and related disorders·2026
查看所有相关文章

相关实验视频

Updated: Jun 13, 2025

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
04:55

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

3.7K

多发性硬化症中的脱脂症.

Taylor R Wicks1, Nasim Nehzat1, Anna Wolska2

  • 1Departments of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA.

Multiple sclerosis and related disorders
|September 11, 2024
PubMed
概括
此摘要是机器生成的。

多发性硬化症 (MS) 患者和健康对照人群之间的失脂症频率没有差异. 然而,更高的高密度脂蛋白颗粒 (HDLP) 度与渐进性多发性硬化症 (PMS) 的残疾减少有关.

关键词:
胆固醇 胆固醇 胆固醇脱脂血症是什么意思 脱脂血症是什么意思这就是为什么LDL,LDL是LDL.脂蛋白质是一种脂蛋白质.

更多相关视频

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

27.0K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.3K

相关实验视频

Last Updated: Jun 13, 2025

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
04:55

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

3.7K
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

27.0K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.3K

科学领域:

  • 生物化学 生化学
  • 神经免疫学 神经免疫学
  • 心血管科学 心血管科学

背景情况:

  • 多发性硬化症 (MS) 是中枢神经系统的一种慢性炎症性疾病.
  • 脱脂症,以异常的脂质水平为特征,是一种常见的并发症,可能对MS的发病和进展产生潜在影响.
  • 了解MS中的脂质谱和脂蛋白颗粒特征对于评估疾病关联和潜在治疗点至关重要.

研究的目的:

  • 确定与健康对照组 (HC) 相比,复发性缓解性多发性硬化症 (RRMS) 和渐进性多发性硬化症 (PMS) 个体中各种失脂症表型的患病率.
  • 研究MS中脱脂症表型和脂蛋白颗粒大小分布之间的关系.
  • 探索脂蛋白样本,残疾分数 (EDSS) 和多样性多样性中PCSK9水平之间的关联.

主要方法:

  • 一项涉及203名高血压,221名RRMS和126名PMS参与者的横截面研究.
  • 测量了脂质特征 (总胆固醇,HDL-C,甘油三,apoB),并计算了LDL-C亚型.
  • 使用质子NMR分析分析了脂蛋白颗粒大小和度 (TRLP,LDLP,HDLP);PCSK9水平通过免疫测试进行评估.

主要成果:

  • 在HC,RRMS和PMS组中,正常脂血症和失脂血症表型的频率相似.
  • 富含三糖蛋白脂蛋白颗粒 (TRLP) 和小低密度脂蛋白颗粒 (LDLP) 的度显示出从HC到RRMS到PMS的下降趋势.
  • 在PMS患者中,高密度脂蛋白颗粒 (HDLP) 和小密度脂蛋白颗粒 (HDLP) 的较高度与扩大残疾状态量表 (EDSS) 的较低得分有关.

结论:

  • 脱脂症表型的流行在MS患者和健康对照人群之间是可比的.
  • 高密度脂蛋白颗粒度的增加与渐进性多发性硬化症中较不严重的残疾有关.
  • PCSK9的水平与高密度脂质素粒子度相关,特别是小密度脂质素粒子.